Dennis Pessis to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Dennis Pessis has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.056
-
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer. J Urol. 2002 Apr; 167(4):1670-4.
Score: 0.043
-
Renal failure from metastatic breast carcinoma reversed by radiotherapy and chemotherapy. Arch Intern Med. 1984 Aug; 144(8):1679-81.
Score: 0.013